Stockreport

NovAccess Global Announces New License to Advance its Immunotherapy Platform [Yahoo! Finance]

NOVACCESS GLOBAL INC  (XSNX) 
NASDAQ:AMEX Investor Relations: xsunx.com/investors/investor-faqs
PDF suffering from cancers of the central nervous system, today announced the procurement of a new intellectual property license from Cedars-Sinai Medical Center to further [Read more]